Endoscopic Submucosal Dissection Registry

Launched by CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY · Sep 10, 2023

Keywords

ClinConnect Summary

The Endoscopic Submucosal Dissection (ESD) Registry is a clinical trial that aims to collect information about patients with early-stage or pre-cancerous lesions in the digestive tract, including the stomach, esophagus, and colon. The goal is to better understand how the ESD technique, a minimally invasive procedure, can be used to treat these conditions effectively. This study is currently recruiting participants who are 18 years or older and have specific types of lesions, such as adenomas or neuroendocrine tumors, that are located in the mucosa of the digestive tract.

If you are eligible and choose to participate, you will be asked to provide your consent and share information about your condition and treatment. The study is open to all genders and is specifically looking for those with certain types of lesions that can potentially be treated with ESD. This research will help improve future treatments and outcomes for patients with similar conditions, making it an important step in advancing care for digestive tract neoplasms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • epithelial pre-neoplastic (eg. adenoma, dysplasia) lesion on the esophageal, gastric, duodenal or colorectal mucosa
• • non-epithelial (eg. neuroendocrine tumor) lesion on the esophageal, gastric, duodenal or colorectal mucosa
• • age \> 18 years old
• • informed consent
• Exclusion Criteria:
• • age \< 18 years old
• • no informed consent